More precisely, it was found that the Asp358Ala variant in the IL-6 receptor gene, which attenuates IL-6 signaling on hepatocytes, monocytes, and macrophages, was associated with reduced production of CRP and fibrinogen, and subsequently, a reduced risk of CHD [60, 61]. The gene discussed is CRP; the disease is coronary artery disorder.